0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV60.47%PremiumApr 4, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma7.23Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Luminar Technologies Stock Discussion
Investors are still feeling nervy and jittery ahead of the big day where reciprocal tariffs will come into effect.
If there is a broad-based sanction on all countries from Trump, it could escalate to a global trade war, with a lot of tit for tat going on. This is definitely not good for US and global economy
All that said, what if the market is pricing in
the worst...
Luminar Collaborates With Caterpillar To Integrate LiDAR Technology Into Caterpillar's Next Generation Autonomous Solution
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
Gapping Up
$Luminar Technologies (LAZR.US)$ jumped 7.2% after its fourth-quarter loss was less than anticipated and its $22.5 million in revenue exceeded the $17.8 million forecast. The company also reported an adjusted gross profit of $14 million, against Wall Street's expectation of a $12 million loss.
$Alnylam Pharmaceuticals (ALNY.US)$ increased 4.5% Premarket premarket after FDA expands approval for drug to trea...
No comment yet